Europeiska unionen - slovenska - EMA (European Medicines Agency)

piramal critical care b.v. - sugammadex sodium - neuromuskularna blokada - sugamadeks - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Europeiska unionen - slovenska - EMA (European Medicines Agency)

extrovis eu ltd. - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Europeiska unionen - slovenska - EMA (European Medicines Agency)

mylan ireland limited - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Europeiska unionen - slovenska - EMA (European Medicines Agency)

pfizer europe ma eeig - somatrogon - growth and development - hipofiza in hypothalamic hormoni in analogi - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.

Europeiska unionen - slovenska - EMA (European Medicines Agency)

merck sharp & dohme b.v. - sugamadeks - neuromuskularna blokada - vsi drugi terapevtski izdelki - zavrnitev nevromuskularne blokade, ki jo inducira rocuronium ali vecuronium. za peadiatric prebivalstva: sugammadex je priporočena le za rutinsko odprave rokuronij zaradi blokade pri otrocih in mladostnikih.

Europeiska unionen - slovenska - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Europeiska unionen - slovenska - EMA (European Medicines Agency)

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - zavrnitev nevromuskularne blokade, ki jo inducira rocuronium ali vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kapljice za oko

Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

raztopina za injiciranje - atropin

Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi-aventis d.o.o. - adrenalin - raztopina za injiciranje - adrenalin 1 mg / 1 ml - adrenalin